CompletedNot Applicable

Cholecystectomy TIming for Mild Acute Biliary Pancreatitis [CTIMAP]: a Società Lombarda di Chirurgia Observational Study

Italy445 participantsStarted 2022-04-12

Plain-language summary

CTIMAP is a prospective multicenter observational study on patients with Mild Acute Biliary Pancreatitis (MABP) treated with Same Admission Cholecystectomy (SAC) and Interval Cholecystectomy (IC). The rationale of this study is to investigate the timing of cholecystectomy after MABP applied by Lombard surgeons and compare SAC and IC, with the hypothesis that SAC would reduce the risk of recurrent Gallstones Related Events (GRE) without increasing the difficulty of surgery and postoperative complications.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * to be admitted with a diagnosis of acute pancreatitis, as defined according to 2012 Atlanta Criteria * pancreatitis is mild as defined according to 2012 Atlanta Criteria * the etiology of pancreatitis is a gallstone related (finding of stones or sludge in the gallbladder on in the main biliary duct) * be greater than or equal to 18 years old * provide signed and dated informed consent form * willing to comply with all study procedures and be available during the study Exclusion Criteria: * pregnancy or lactation * pancreatitis not related to a gallstone etiology * chronic pancreatitis * moderately severe or severe pancreatitis * alcohol abuse * anything that would place the individual at increased risk or prevent the individual's full compliance with or completion of the study.

What they're measuring

Rate of 6-month readmission due to GRE after hospitalization for MABP

Timeframe: 6 months

Trial details

NCT IDNCT07234136

SponsorFondazione IRCCS Policlinico San Matteo di Pavia

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31